Cramer’s lightning round: Lucid Group is too dangerous to own here

Brookfield Renewable Partners: “I’ve been skeptical of that one … but I am willing to reopen the books, and see if there isn’t something here we can’t find.”

Crown Holdings: “[Formerly] Crown Cork, I love those guys. … The stock has come down. I think it’s a great industrial. You’ve got a winner.”

Lucid Group: “We don’t want to fool around with that. The thing just goes down and down. I see a trend. … I think that one is just too dangerous.”

Joby Aviation: “Joby Aviation … is like a Jules Verne story. … Let’s leave it like a story and not think of it as a stock.”

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.

Source

Business

Inside the booming business of wellness third spaces and membership clubs

March 7, 2026

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Business

FDA vaccine head will step down in April after string of controversial decisions

March 6, 2026

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Business

FDA reversals leave investors worrying about the fates of other experimental drugs

March 6, 2026

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration. The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]